A detailed history of River Road Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, River Road Asset Management, LLC holds 66,556 shares of ABBV stock, worth $13 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
66,556
Previous 69,130 3.72%
Holding current value
$13 Million
Previous $12.6 Million 9.32%
% of portfolio
0.17%
Previous 0.17%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $398,429 - $465,276
-2,574 Reduced 3.72%
66,556 $11.4 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $7.32 Million - $8.34 Million
-45,772 Reduced 39.84%
69,130 $12.6 Million
Q4 2023

Jan 31, 2024

SELL
$137.6 - $154.97 $377,987 - $425,702
-2,747 Reduced 2.33%
114,902 $17.8 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $511,916 - $592,618
-3,832 Reduced 3.15%
117,649 $17.5 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $653,804 - $813,616
-4,934 Reduced 3.9%
121,481 $16.4 Million
Q1 2023

Apr 27, 2023

BUY
$144.61 - $166.54 $789,136 - $908,808
5,457 Added 4.51%
126,415 $20.1 Million
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $4.59 Million - $5.5 Million
-33,181 Reduced 21.53%
120,958 $19.6 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $322,506 - $369,893
2,403 Added 1.58%
154,139 $20.7 Million
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $4.43 Million - $5.63 Million
-32,193 Reduced 17.5%
151,736 $23.2 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $4.57 Million - $5.67 Million
-34,656 Reduced 15.85%
183,929 $29.8 Million
Q4 2021

Feb 01, 2022

SELL
$107.43 - $135.93 $2.23 Million - $2.82 Million
-20,715 Reduced 8.66%
218,585 $29.6 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $1.9 Million - $2.16 Million
-17,898 Reduced 6.96%
239,300 $25.8 Million
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $3.67 Million - $4.09 Million
-34,895 Reduced 11.95%
257,198 $29 Million
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $2.42 Million - $2.67 Million
-23,694 Reduced 7.5%
292,093 $31.6 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $7.65 Million - $10.3 Million
-95,004 Reduced 23.13%
315,787 $33.8 Million
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $1.88 Million - $2.2 Million
21,853 Added 5.62%
410,791 $36 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $3.87 Million - $5.18 Million
-52,762 Reduced 11.95%
388,938 $38.2 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $1.1 Million - $1.68 Million
-17,129 Reduced 3.73%
441,700 $33.7 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $690,716 - $864,234
-9,576 Reduced 2.04%
458,829 $40.6 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $29.5 Million - $35.5 Million
468,405 New
468,405 $35.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track River Road Asset Management, LLC Portfolio

Follow River Road Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Road Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Road Asset Management, LLC with notifications on news.